Printer Friendly

Bruker Found to Have Infringed Finnigan Patents.

Dusseldorf, Germany 3/31/00-A German court has ruled in favor of Finnigan and its parent company, ThermoQuest, regarding a March 1999 suit (see IBO 3/15/99) against Bruker Daltronik GmbH and Hewlett Parckard GmbH (now Agilent) alleging infringement of three patents related to Bruker and Agilent's Esquire series MS system. The court ruled that the sale of the Esquire in Germany infringed two of Finnigan's patents and that Bruker must pay damages to Finnigan, estimated by Bruker at $240,000, and can no longer sell its ion trap MS systems in Germany if Finnigan posts the required bond. A ruling on the third patent is pending. Rulings are expected at a later date in Germany regarding patent infringement in the UK, France, Sweden and Switzerland, and in the US District Court for Massachusetts.

This is a setback for Bruker, which is one of the few companies with ion trap technology. This will also likely affect Agilent, which uses Bruker's ion trap technology in its 1100 Series LC-MS. Bruker may also be required to indemnify Agilent for damages and expenses. From 1996 to 1999, sales for Bruker's ion trap MS products worldwide totaled over $19 million, with 1999 sales exceeding $8 million as a result of the Agilent relationship.
COPYRIGHT 2000 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Bruker Found to Have Infringed Finnigan Patents.
Publication:Instrument Business Outlook
Geographic Code:1USA
Date:Apr 15, 2000
Words:210
Previous Article:Bruker Files IPO.
Next Article:Ruling in Affymetrix Patent Case.
Topics:


Related Articles
Finnigan Files German Lawsuit Against HP and Bruker.
FT-MS Vendors Look into New Possibilities.
Executive Briefing.
Executive Briefing.
Endpoint: Ion Trap Litigation.
Thermo and Bruker End Litigation.
Micromass partners with Beyond Genomics. (Executive briefing: news, trends & market intelligence for instrument executives).
It's a mass spec world: 2002's new products.
Waters' mass spec transactions. (Executive briefing: news, trends & market intelligence for instrument executives).
Patent litigation increases for selected techniques.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters